Page last updated: 2024-08-17

quinoxalines and ATLL

quinoxalines has been researched along with ATLL in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishikawa, C; Mori, N; Senba, M1
Bazarbachi, A; Bonnet, PA; Deleuze-Masquéfa, C; El-Hajj, H; El-Sabban, ME; Hermine, O; Kfoury, Y; Lepelletier, Y; Moarbess, G1

Other Studies

2 other study(ies) available for quinoxalines and ATLL

ArticleYear
Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
    International journal of oncology, 2018, Volume: 53, Issue:2

    Topics: Animals; CDC2 Protein Kinase; Cell Line, Tumor; Coculture Techniques; Cyclin B1; Gene Expression Regulation, Neoplastic; Humans; Indolizines; Leukemia-Lymphoma, Adult T-Cell; Leukocytes, Mononuclear; Mice; Mitogen-Activated Protein Kinase Kinases; Neoplasm Transplantation; Phosphorylation; Quinoxalines; Up-Regulation

2018
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma.
    Blood, 2008, Apr-01, Volume: 111, Issue:7

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspases; Cell Division; Cytochromes c; G2 Phase; Human T-lymphotropic virus 1; Humans; Imiquimod; Inflammation; Inhibitor of Apoptosis Proteins; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Activation; Lymphoma, T-Cell; Membrane Potential, Mitochondrial; NF-kappa B; Quinoxalines; Skin Neoplasms; Tumor Suppressor Protein p53

2008